> Boehringer Ingelheim reported positive results for its HIV treatment, Aptivus. Release
> Cubist Pharmaceuticals has won priority review for Cubicin as a treatment for heart valve infections. Article
> Solexa has struck a deal for a $65 million private placement. Release
> Sweden's Medivir and China's Hengrui Medicine Company have extended their two-year research collaboration developing drugs against COPD. Release
> Canada's SemBioSys Genetics has arranged $2.5 million in long-term debt financing. Release
> Canada's AEterna Zentaris has completed enrollment in a Phase II study of ozarelix in benign prostatic hyperplasia. Release
> Neurome has expanded its research collaboration with Wyeth. Release
> Carrington Laboratories of Irving, TX, has closed on a $5 million private placement. Release
And Finally… The number of people infected with the HIV virus has climbed to a record 40.3 million people, most in the developing world. Article